Sector pending / Electromedical and Electrotherapeutic ApparatusUpdated 2026-05-10 22:07 UTC

BCBA/ABT stock hub

BCBA/ABT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BCBA/ABTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

204.5T

Buenos Aires Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BCBA/ABT

In the news

Latest news · BCBA/ABT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15

P25 n/aP50 n/aP75 n/a

Trailing P/E23.7

P25 n/aP50 n/aP75 n/a

ROE12.3

P25 n/aP50 n/aP75 n/a

ROIC9.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BCBA/ABT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

228

Groups with data

Currency

USD

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	AR
Employees	115,000
Employees Change	7,000%
Employees Change Percent	6.09
Enterprise value	ARS 242.8T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Electromedical and Electrotherapeutic Apparatus
Last refreshed	2026-05-10
Market cap	ARS 204.5T
Price	ARS 31,300
Price currency	ARS
Rev Per Employee	542,202,081.18x
Sic	3845
Symbol	bcba/ABT
Website	https://www.abbott.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.22%
EV Earnings	28.11x
EV/EBIT	20.32x
EV/EBITDA	14.37x
EV/FCF	23.82x
EV/Sales	3.86x
FCF yield	4.98%
Forward P/E	14.97x
P/B ratio	2.81x
P/E ratio	23.68x
P/S ratio	3.28x
PE Ratio10 Y	50.34x
PE Ratio3 Y	27.72x
PE Ratio5 Y	27.88x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	19.01%
EBITDA Margin	26.02%
FCF margin	16.35%
Gross margin	56.5%
Gross Profit	ARS 35.2T
Gross Profit Growth	7.63%
Gross Profit Growth Q	6.52%
Gross Profit Growth3 Y	3.39%
Gross Profit Growth5 Y	3.61%
Net Income	ARS 8.6T
Net Income Growth	-53.52%
Net Income Growth Q	-18.72%
Net Income Growth3 Y	2.62%
Net Income Growth5 Y	1.88%
Pretax Margin	18.03%
Profit Margin	13.91%
Profit Per Employee	ARS 75.1M
ROA	5.59
Roa5y	6.84
ROCE	9.32
ROE	12.33
Roe5y	19.7
ROIC	9.63
Roic5y	14.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	71.24%
Cagr1y	-18.87%
Cagr3y	36.51%
Cagr5y	47.27%
Div CAGR10	78.65%
Div CAGR3	125.66%
Div CAGR5	96.36%
EPS Growth	-53.65
EPS Growth Q	-19.74
EPS Growth3 Y	2.78
EPS Growth5 Y	2.27
FCF Growth	10.83%
FCF Growth Q	-1.82%
FCF Growth3 Y	2.64%
FCF Growth5 Y	-0.61%
OCF Growth	5.74%
OCF Growth Q	-7.2%
OCF Growth10 Y	12.67%
OCF Growth3 Y	3.01%
OCF Growth5 Y	-0.74%
Revenue Growth	6.59x
Revenue Growth Q	7.78x
Revenue Growth3 Y	2.83x
Revenue Growth5 Y	3.87x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ARS 0.47
Assets	ARS 152.6T
Cash	ARS 10.1T
Current Assets	ARS 35.7T
Current Liabilities	ARS 25.7T
Debt	ARS 47.2T
Debt EBITDA	ARS 2.81
Debt Equity	ARS 0.65
Debt FCF	ARS 4.63
Equity	ARS 72.8T
Interest Coverage	16.01
Liabilities	ARS 79.8T
Long Term Assets	ARS 116.9T
Long Term Liabilities	ARS 54T
Net Cash	ARS -37.1T
Net Cash By Market Cap	ARS -18.13
Net Debt EBITDA	ARS 2.29
Net Debt Equity	ARS 0.51
Net Debt FCF	ARS 3.64
Tangible Book Value	ARS -1.4T
Tangible Book Value Per Share	ARS -821

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.39
Inventory Turnover	2.88
Net Working Capital	ARS 5.9T
Quick ratio	0.84
Working Capital	ARS 9.9T
Working Capital Turnover	ARS 7,217

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.03%
Dividend Growth	61.19%
Dividend Growth Years	12%
Dividend per share	ARS 601
Dividend Years	27
Dividend Yield	1.92%
Ex Div Date	2026-04-15
Last Dividend	ARS 212
Payout Frequency	Quarterly
Payout Ratio	66.73%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	21,560.37%
1Y total return	-18.86%
200-day SMA	43,910.8
3Y total return	154.42%
50-day SMA	37,673.6
50-day SMA vs 200-day SMA	50under200
5Y total return	592.59%
All Time High	53,525
All Time High Change	-41.52%
All Time High Date	2025-09-19
All Time Low	55.38
All Time Low Change	56,423.7%
All Time Low Date	2011-07-21
ATR	917.4
Ch YTD	-34.49
High	32,480
High52	53,525
High52 Date	2025-09-19
High52ch	-41.52%
Low	31,240
Low52	31,240
Low52 Date	2026-05-08
Low52ch	0.19%
Ma50ch	-16.92%
Price vs 200-day SMA	-28.72%
RSI	24.17
RSI Monthly	42.93
RSI Weekly	23.02
Sharpe ratio	-0.53x
Sortino ratio	-0.53
Total Return	1.89%
Tr YTD	-33.91
Tr1m	-16.76%
Tr1w	-4.46%
Tr3m	-23.41%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ARS 11.9T
Operating Income Growth	9.76
Operating Income Growth Q	-18.26
Operating Income Growth3 Y	3.54
Operating Income Growth5 Y	4.05
Operating margin	19.01

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,731,228,666%
Net Borrowing	25,031,780,740,549
Shares Insiders	0.49%
Shares Institutions	80.5%
Shares Qo Q	0%
Shares Yo Y	0.03%
Short Ratio	1.85

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ARS 9.2T
Average Volume	3,865.65x
Bv Per Share	41,292
CAPEX	ARS -2.9T
Ch10y	19,462.5
Ch1m	-17.24
Ch1w	-4.46
Ch1y	-20
Ch3m	-23.84
Ch3y	146.3
Ch5y	563.1
Ch6m	-32.43
Change	-3.22%
Change From Open	-3.63
Close	32,340
Days Gap	0.43
Depreciation Amortization	4,423,954,991,471
Dollar Volume	208,520,600
Earnings Date	2026-04-16
EBIT	ARS 11.9T
EBITDA	ARS 16.2T
EPS	ARS 4,932
F Score	5
FCF	ARS 10.2T
FCF EV Yield	4.2x
Financing CF	18,041,187,408,300
Fiscal Year End	December
Founded	1,888
Goodwill	49,262,130,494,657
Graham Number	18202.04345
Graham Upside	-41.85
Income Tax	ARS 2.6T
Investing CF	-30,774,599,181,200
Is Primary Listing	0
Last Earnings Date	2026-04-16
Last Report Date	2026-03-31
Last Split Date	2020-10-22
Last Split Type	Forward
Lynch Fair Value	ARS 6,608
Lynch Upside	-78.89
Ma150	43,685.2
Ma150ch	-28.35%
Ma20	34,447
Ma20ch	-9.14%
Net CF	374,390,212,700
Next Earnings Date	2026-07-15
Open	32,480
P FCF Ratio	20.07
P OCF Ratio	15.64
Payment Date	2026-05-15
Position In Range	4.84
Ppne	17,311,189,038,709
Price Date	2026-05-08
Price EBITDA	ARS 12.61
Relative Volume	1.72x
Revenue	62,353,239,335,800x
SBC By Revenue	1.53x
Share Based Comp	956,007,480,400
Tax By Revenue	4.12x
Tax Rate	22.87%
Tr6m	-31.83%
Volume	6,662
Z Score	3.65

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BCBA/ABT dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.9%

$601 annual per share

Payout ratio

+66.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+96.4%

12 consecutive years of growth

Total shareholder yield

+1.9%

Next ex-dividend date: 2026-04-15

Performance

BCBA/ABT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BCBA/ABT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+80.5%

Share of float held by funds and institutions

Insider ownership

+0.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BCBA/ABT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

24.2

Below 30: short-term oversold

Price vs 200-day MA

-28.7%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.53

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BCBA/ABT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bcba/ABT stock rating?

bcba/ABT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bcba/ABT analysis?

The full report lives at /stocks/bcba/ABT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bcba/ABT?

The latest report frames bcba/ABT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bcba/ABT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.